Drug intelligence / Profile preview

PreserVision

Development stage
Unknown
Lead developer
Bausch + Lomb
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

PreserVision is a line of ocular nutritional supplements developed by Bausch + Lomb, specifically formulated based on the findings of the Age-Related Eye Disease Studies (AREDS and AREDS2) conducted by the National Eye Institute. The primary indication for these supplements is to reduce the risk of progression in patients with intermediate to advanced age-related macular degeneration (AMD). The AREDS2 formulation, which is the current clinical standard, typically contains high doses of antioxidant vitamins and minerals, including Vitamin C, Vitamin E, zinc, copper, lutein, and zeaxanthin. These components work synergistically to neutralize reactive oxygen species and provide essential nutrients to the macula, thereby slowing the degenerative processes associated with AMD. Unlike standard multivitamins, PreserVision contains specific levels of these nutrients that were clinically proven to be effective in large-scale clinical trials.

Brand names
PreserVision
Other names
AREDS formulaAREDS2 formulaAREDS-2 formulaAREDS 2 formula

Beyond the preview

Go deeper on PreserVision.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreserVision.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call